Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

Literature DB >> 1624678

Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

Abstract

We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1992 PMID： 1624678 DOI： 10.1007/BF03348702

Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256

31 in total

1. McCune-Albright syndrome with acromegaly.

Authors: K K Pun; G Chan; A Kung; K Lam; F L Chan; C Wang
Journal: Horm Metab Res Date: 1989-09 Impact factor: 2.936

2. Albright's syndrome--thirty years later. (Polyostotic fibrous dysplasia).

Authors: H E MacMahon
Journal: Pathol Annu Date: 1971

3. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).

Authors: C Polychronakos; G Tsoukas; J R Ducharme; J Letarte; R Collu
Journal: J Endocrinol Invest Date: 1982 Sep-Oct Impact factor: 4.256

4. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.

Authors: L A Frohman; J L Thominet; C B Webb; M L Vance; H Uderman; J Rivier; W Vale; M O Thorner
Journal: J Clin Invest Date: 1984-05 Impact factor: 14.808

5. Polyostotic fibrous dysplasia with acromegaly.

Authors: R I Harris
Journal: Am J Med Date: 1985-03 Impact factor: 4.965

6. Hyperprolactinaemia in a patient with the McCune-Albright Syndrome.

Authors: D Carr; I K Mathie; A R Manners; C Colman
Journal: Br J Obstet Gynaecol Date: 1979-04

7. The McCune-Albright syndrome.

Authors: N Mauras; R M Blizzard
Journal: Acta Endocrinol Suppl (Copenh) Date: 1986

8. The Albright syndrome associated with acromegaly: report of a case and review of the literature.

Authors: A Lipson; T H Hsu
Journal: Johns Hopkins Med J Date: 1981-07

9. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.

Authors: T Shibasaki; M Hotta; A Masuda; T Imaki; N Obara; N Hizuka; K Takano; I Wakabayashi; H Demura; N Ling
Journal: J Clin Endocrinol Metab Date: 1986-07 Impact factor: 5.958

10. Gigantism associated with McCune-Albright's syndrome.

Authors: H Nakagawa; A Nagasaka; T Sugiura; K Nakagawa; Y Yabe; N Nihei; M Hirooka; M Itoh; A Nakai; T Ohyama
Journal: Horm Metab Res Date: 1985-10 Impact factor: 2.936

8 in total

Review 1. Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors: Paraskevi Salpea; Constantine A Stratakis
Journal: Mol Cell Endocrinol Date: 2013-09-05 Impact factor: 4.102

2. Expert's comment concerning Grand Rounds case entitled "Scoliosis correction surgery for patients with McCune-Albright syndrome using pedicle screws: a report of two cases with different characteristics and a review of the literature" (K. Yamane, M. Tanaka, Y. Sugimoto, H. Misawa and T. Ozaki).

Authors: Panagiotis Korovessis
Journal: Eur Spine J Date: 2015-03-17 Impact factor: 3.134

Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

1. McCune-Albright syndrome with acromegaly.

2. Albright's syndrome--thirty years later. (Polyostotic fibrous dysplasia).

3. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).

4. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.

5. Polyostotic fibrous dysplasia with acromegaly.

6. Hyperprolactinaemia in a patient with the McCune-Albright Syndrome.

7. The McCune-Albright syndrome.

8. The Albright syndrome associated with acromegaly: report of a case and review of the literature.

9. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.

10. Gigantism associated with McCune-Albright's syndrome.

Review 1. Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

2. Expert's comment concerning Grand Rounds case entitled "Scoliosis correction surgery for patients with McCune-Albright syndrome using pedicle screws: a report of two cases with different characteristics and a review of the literature" (K. Yamane, M. Tanaka, Y. Sugimoto, H. Misawa and T. Ozaki).

Review 3. Thyroid hormone metabolites and analogues.

4. McCune-Albright syndrome: surgical and therapeutic challenges in GH-secreting pituitary adenomas.

Review 5. Acromegaly and McCune-Albright syndrome.

6. McCune Albright syndrome in association with excessive GH secretion: case report.

7. McCune-Albright syndrome.

8. A case of McCune-Albright syndrome with associated multiple endocrinopathies.